Recruiting
A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer
NCT05838521
- Conditions
- Cervical Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
- Locations
-
- Smilow Cancer Hospital at Yale New Haven New Haven, Connecticut, United States
- Cleveland Clinic Cleveland, Ohio, United States